-
1
-
-
0003661910
-
-
accessed January,13, 2010
-
World Health Organization. World Health Statistics 2009. www.who.int/whosis/whostat/2009/en/print. html (accessed January 13, 2010).
-
(2009)
World Health Statistics
-
-
-
2
-
-
4444382796
-
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study
-
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-952.
-
(2004)
Lancet
, vol.364
, pp. 937-952
-
-
Yusuf, S.1
Hawken, S.2
Ounpuu, S.3
Dans, T.4
Avezum, A.5
Lanas, F.6
McQueen, M.7
Budaj, A.8
Pais, P.9
Varigos, J.10
Lisheng, L.11
-
3
-
-
72949131359
-
Operon: A group of genes with the expression coordinated by an operator
-
Jacob F, Perrin D, Sanchez C, Monod J: Operon: a group of genes with the expression coordinated by an operator. C R Hebd Seances Acad Sci 1960; 250: 1727-1729.
-
(1960)
C R Hebd Seances Acad Sci
, vol.250
, pp. 1727-1729
-
-
Jacob, F.1
Perrin, D.2
Sanchez, C.3
Monod, J.4
-
4
-
-
26444493132
-
Nutrigenomics and nutrigenetics: The emerging faces of nutrition
-
Mutch DM, Wahli W, Williamson G: Nutrigenomics and nutrigenetics: the emerging faces of nutrition. FASEB J 2005;19:1602-1616.
-
(2005)
FASEB J
, vol.19
, pp. 1602-1616
-
-
Mutch, D.M.1
Wahli, W.2
Williamson, G.3
-
5
-
-
0040006374
-
-
Nutrition: Special Report July 22
-
Nutrition: Special Report. The Economist, July 22, 2007.
-
(2007)
The Economist
-
-
-
6
-
-
58249135635
-
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: A cohort study
-
Collet J P, Hulot JS, Pena A, Villard E, Esteve JB, Silvain J, Payot L, Brugier D, Cayla G, Beygui F, Bensimon G, Funck-Brentano C, Montalescot G: Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. Lancet 2009;373:309-317.
-
(2009)
Lancet
, vol.373
, pp. 309-317
-
-
Collet, J.P.1
Hulot, J.S.2
Pena, A.3
Villard, E.4
Esteve, J.B.5
Silvain, J.6
Payot, L.7
Brugier, D.8
Cayla, G.9
Beygui, F.10
Bensimon, G.11
Funck-Brentano, C.12
Montalescot, G.13
-
7
-
-
0347418277
-
Arachidonate 5-lipoxy-genase promoter genotype, dietary arachidonic acid, and atherosclerosis
-
Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R, Lusis AJ, Mehrabian M: Arachidonate 5-lipoxy-genase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004;350:29-37.
-
(2004)
N Engl J Med
, vol.350
, pp. 29-37
-
-
Dwyer, J.H.1
Allayee, H.2
Dwyer, K.M.3
Fan, J.4
Wu, H.5
Mar, R.6
Lusis, A.J.7
Mehrabian, M.8
-
8
-
-
0346787907
-
From asthma to atherosclerosis; 5-lipoxygenase, leukotrienes, and inflammation
-
De Caterina R, Zampolli A: From asthma to atherosclerosis; 5-lipoxygenase, leukotrienes, and inflammation. N Engl J Med 2004;350:4-7.
-
(2004)
N Engl J Med
, vol.350
, pp. 4-7
-
-
De Caterina, R.1
Zampolli, A.2
-
9
-
-
0028172777
-
The omega-3 fatty acid docosa-hexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells
-
De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P: The omega-3 fatty acid docosa-hexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 1994; 14:1829-1836.
-
(1994)
Arterioscler Thromb
, vol.14
, pp. 1829-1836
-
-
De Caterina, R.1
Cybulsky, M.I.2
Clinton, S.K.3
Gimbrone Jr., M.A.4
Libby, P.5
-
10
-
-
33750059762
-
The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition
-
Massaro M, Habib A, Lubrano L, Del Turco S, Lazzerini G, Bourcier T, Weksler BB, De Caterina R: The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci USA 2006;103:15184-15189.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 15184-15189
-
-
Massaro, M.1
Habib, A.2
Lubrano, L.3
Del Turco, S.4
Lazzerini, G.5
Bourcier, T.6
Weksler, B.B.7
De Caterina, R.8
-
11
-
-
0036136232
-
Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: The Framingham Study
-
Ordovas JM, Corella D, Cupples LA, Demissie S, Kelleher A, Coltell O, Wilson P W, Schaefer EJ, Tucker K: Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study. Am J Clin Nutr 2002;75:38-46.
-
(2002)
Am J Clin Nutr
, vol.75
, pp. 38-46
-
-
Ordovas, J.M.1
Corella, D.2
Cupples, L.A.3
Demissie, S.4
Kelleher, A.5
Coltell, O.6
Wilson, P.W.7
Schaefer, E.J.8
Tucker, K.9
-
12
-
-
40649101216
-
Clinical trials and clinical judgment
-
DeMaria AN: Clinical trials and clinical judgment. J Am Coll Cardiol 2008;51:1120-1122.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 1120-1122
-
-
Demaria, A.N.1
-
13
-
-
0035811739
-
Clinical practice: Post-menopausal hormone-replacement therapy
-
Manson JE, Martin KA: Clinical practice: post-menopausal hormone-replacement therapy. N Engl J Med 2001;345:34-40.
-
(2001)
N Engl J Med
, vol.345
, pp. 34-40
-
-
Manson, J.E.1
Martin, K.A.2
-
14
-
-
36348975228
-
Effects of torce-trapib in patients at high risk for coronary events
-
Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B: Effects of torce-trapib in patients at high risk for coronary events. N Engl J Med 2007;357:2109-2122.
-
(2007)
N Engl J Med
, vol.357
, pp. 2109-2122
-
-
Barter, P.J.1
Caulfield, M.2
Eriksson, M.3
Grundy, S.M.4
Kastelein, J.J.5
Komajda, M.6
Lopez-Sendon, J.7
Mosca, L.8
Tardif, J.C.9
Waters, D.D.10
Shear, C.L.11
Revkin, J.H.12
Buhr, K.A.13
Fisher, M.R.14
Tall, A.R.15
Brewer, B.16
-
15
-
-
38049130261
-
Letting the genome out of the bottle: Will we get our wish?
-
Hunter DJ, Khoury MJ, Drazen JM: Letting the genome out of the bottle: will we get our wish? N Engl J Med 2008;358:105-107.
-
(2008)
N Engl J Med
, vol.358
, pp. 105-107
-
-
Hunter, D.J.1
Khoury, M.J.2
Drazen, J.M.3
-
16
-
-
58949083575
-
Genetic screening: Programs, principles, and research-thirty years later
-
Reviewing the recommendations of the Committee for the Study of Inborn Errors of Metabolism (SIEM)
-
Simopoulos AP: Genetic screening: programs, principles, and research-thirty years later. Reviewing the recommendations of the Committee for the Study of Inborn Errors of Metabolism (SIEM). Public Health Genomics 2009;12:105-111.
-
(2009)
Public Health Genomics
, vol.12
, pp. 105-111
-
-
Simopoulos, A.P.1
-
17
-
-
69249115842
-
Learning from the past and looking to the future
-
Capron A, Bice S: Learning from the past and looking to the future. J Nutrigenet Nutrigenomics 2009; 2:85-90.
-
(2009)
J Nutrigenet Nutrigenomics
, vol.2
, pp. 85-90
-
-
Capron, A.1
Bice, S.2
-
18
-
-
77956162094
-
-
accessed January 13, 2010
-
Simopoulos AP: ISNN Home. http://www.isnn.info (accessed January 13, 2010).
-
ISNN Home
-
-
Simopoulos, A.P.1
|